Human cytomegalovirus infection in humanized liver chimeric mice

Hepatology Research

Volumn 43, Issue 6, 2013, Pages 679-684

  Kawahara, Toshiyasu ^a   Lisboa, Luiz Filipe ^a   Cader, Sonia ^a   Douglas, Donna N ^a   Nourbakhsh, Mahra ^a   Pu, Christopher H ^a   Lewis, Jamie T ^a   Churchill, Thomas A ^a   Humar, Atul ^a   Kneteman, Norman M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytomegalovirus; Hepatocyte transplantation; Human liver chimeras

Indexed keywords

GANCICLOVIR; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CELL TRANSFER; CHIMERA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; LIVER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 84878788641     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01116.x     Document Type: Article

References (19)

1. Kotton C, Kumar D, Caliendo A etal. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779-795.
2. Bronsther O, Makowka L, Jaffe R etal. Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988; 24: 423-434.
3. Barkholt L, Ehrnst A, Veress B. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens. Scand J Gastroenterol 1994; 29: 553-560.
4. Paya C, Hermans P, Wiesner R etal. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752-758.
5. Kern E. Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antiviral Res 2006; 71: 164-171.
6. Mercer DF, Schiller DE, Elliott JF etal. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7: 927-933.
7. Kneteman NM, Mercer DF. Mice with chimeric human livers: Who says supermodels have to be tall? Hepatology 2005; 41: 703-706.
8. Sacci JJB, Alam U, Douglas D etal. Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol 2006; 36: 353-360.
9. Morosan S, Hez-Deroubaix S, Lunel F etal. Liver-stage development of plasmodium falciparum, in a humanized mouse model. J Infect Dis 2006; 193: 996-1004.
10. Kawahara T, Toso C, Douglas DN etal. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl 2010; 16: 974-982.
11. Kneteman NM, Weiner AJ, O'Connell J etal. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology 2006; 43: 1346-1353.
12. Sacher T, Mohr C, Weyn A, Schlichting C, Koszinowski U, Ruzsics Z. The role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol 2012; 91: 70-77.
13. Sinzger C, Bissinger A, Viebahn R etal. Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J Infect Dis 1999; 180: 976-986.
14. Wilkinson G, Tomasec P, Stanton R etal. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008; 41: 206-212.
15. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HW. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 2005; 79: 661-667.
16. Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RAW, Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood 2008; 112: 914-915.
17. Ohira M, Ishiyama K, Tanaka Y etal. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest 2009; 119: 3226-3235.
18. Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 2006; 43: 362-372.
19. Sacher T, Podlech J, Mohr C etal. The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 2008; 3: 263-272.